相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New advancements in CRISPR based gene therapy of Duchenne muscular dystrophy
Atieh Eslahi et al.
GENE (2023)
Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs
Xi Xiang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine
Nalinda B. Wasala et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
CRISPR-Generated Animal Models of Duchenne Muscular Dystrophy
Kenji Rowel Q. Lim et al.
GENES (2020)
Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing
Yi-Li Min et al.
MOLECULAR THERAPY (2020)
High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of DMD Gene Repair Tools and Strategies in Human Cells
Marcella Brescia et al.
CELLS (2020)
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
Chengmei Sun et al.
GENES (2020)
Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model
Alper Yavas et al.
PLOS ONE (2020)
Gene therapies in canine models for Duchenne muscular dystrophy
Peter P. Nghiem et al.
HUMAN GENETICS (2019)
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
Yi-Li Min et al.
SCIENCE ADVANCES (2019)
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene
Tatiana Egorova et al.
DISEASE MODELS & MECHANISMS (2019)
Generation of two Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD02 and DMD03 (MUNIi001-A and MUNIi003-A)
Sarka Jelinkova et al.
STEM CELL RESEARCH (2019)
CRISPR Correction of Duchenne Muscular Dystrophy
Yi-Li Min et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Predicting the mutations generated by repair of Cas9-induced double-strand breaks
Felicity Allen et al.
NATURE BIOTECHNOLOGY (2019)
Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride
Hotake Takizawa et al.
SCIENTIFIC REPORTS (2019)
Variable rescue of microtubule and physiological phenotypes in mdx muscle expressing different miniaturized dystrophins
D'anna M. Nelson et al.
HUMAN MOLECULAR GENETICS (2018)
A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping
Takenori Shimo et al.
JOURNAL OF HUMAN GENETICS (2018)
Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
Seuk-Min Ryu et al.
NATURE BIOTECHNOLOGY (2018)
Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing
Chengzu Long et al.
SCIENCE ADVANCES (2018)
CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
Benjamin L. Duchene et al.
MOLECULAR THERAPY (2018)
Predictable and precise template-free CRISPR editing of pathogenic variants
Max W. Shen et al.
NATURE (2018)
Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
Yusuke Echigoya et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
CRISPR-Cas9 technology: applications and human disease modelling
Raul Torres-Ruiz et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2017)
In vivo and in vitro disease modeling with CRISPR/Cas9
Tomoko Kato et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2017)
Exon skipping: a first in class strategy for Duchenne muscular dystrophy
Erik H. Niks et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy
Yusuke Echigoya et al.
MOLECULAR THERAPY (2017)
CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR Cas9 nuclease off-targets
Shengdar Q. Tsai et al.
NATURE METHODS (2017)
Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
Leonela Amoasii et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Caroline Le Guiner et al.
NATURE COMMUNICATIONS (2017)
Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy
Quynh Nguyen et al.
JOURNAL OF PERSONALIZED MEDICINE (2017)
Applications of CRISPR-Cas systems in neuroscience
Matthias Heidenreich et al.
NATURE REVIEWS NEUROSCIENCE (2016)
CRISPR/Cas9 in Genome Editing and Beyond
Haifeng Wang et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
Courtney S. Young et al.
CELL STEM CELL (2016)
Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity
Josh Tycko et al.
MOLECULAR CELL (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle
Erik P. Rader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The emerging role of viral vectors as vehicles for DMD gene editing
Ignazio Maggio et al.
GENOME MEDICINE (2016)
Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
Jean-Paul Iyombe-Engembe et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
Ignazio Maggio et al.
SCIENTIFIC REPORTS (2016)
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
Joe W. McGreevy et al.
DISEASE MODELS & MECHANISMS (2015)
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Catherine L. Bladen et al.
HUMAN MUTATION (2015)
CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling
Raul Torres-Ruiz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors
Xiaoling Wang et al.
NATURE BIOTECHNOLOGY (2015)
Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells
Daesik Kim et al.
NATURE METHODS (2015)
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
David G. Ousterout et al.
NATURE COMMUNICATIONS (2015)
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
Hongmei Lisa Li et al.
STEM CELL REPORTS (2015)
In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy
Yusuke Echigoya et al.
PLOS ONE (2015)
The Dystrophin Complex: Structure, Function, and Implications for Therapy
Quan Q. Gao et al.
COMPREHENSIVE PHYSIOLOGY (2015)
Targeted Genome Editing Tools for Disease Modeling and Gene Therapy
Mi Cai et al.
CURRENT GENE THERAPY (2014)
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
Suresh Ramakrishna et al.
GENOME RESEARCH (2014)
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
Sojung Kim et al.
GENOME RESEARCH (2014)
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2014)
Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2014)
Fusion of catalytically inactive Cas9 to Fokl nuclease improves the specificity of genome modification
John P. Guilinger et al.
NATURE BIOTECHNOLOGY (2014)
Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
Chengzu Long et al.
SCIENCE (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
Gene Correction of a Duchenne Muscular Dystrophy Mutation by Meganuclease-Enhanced Exon Knock-In
Linda Popplewell et al.
HUMAN GENE THERAPY (2013)
Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
David G. Ousterout et al.
MOLECULAR THERAPY (2013)
AAV Genome Loss From Dystrophic Mouse Muscles During AAV-U7 snRNA-mediated Exon-skipping Therapy
Maeva Le Hir et al.
MOLECULAR THERAPY (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands
Juliet A. Ellis et al.
NEUROMUSCULAR DISORDERS (2013)
Early neurodevelopmental assessment in Duchenne muscular dystrophy
Marika Pane et al.
NEUROMUSCULAR DISORDERS (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Gene therapy for muscular dystrophy: Lessons learned and path forward
Jerry R. Mendell et al.
NEUROSCIENCE LETTERS (2012)
Mammalian Models of Duchenne Muscular Dystrophy: Pathological Characteristics and Therapeutic Applications
Akinori Nakamura et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Endonucleases: tools to correct the dystrophin gene
Joel Rousseau et al.
JOURNAL OF GENE MEDICINE (2011)
Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders
Kamel Mamchaoui et al.
SKELETAL MUSCLE (2011)
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Michelle Christian et al.
GENETICS (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials
Linda J. Popplewell et al.
NEUROMUSCULAR DISORDERS (2010)
Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in Duchenne Muscular Dystrophy Cells
Soraya Chaouch et al.
HUMAN GENE THERAPY (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
Annemieke Aartsma-Rus et al.
RNA (2007)
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
BMC MEDICAL GENETICS (2007)
Dystrophin, its interactions with other proteins, and implications for muscular dystrophy
James M. Ervasti
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy:: Therapeutic perspectives of autologous myoblast transplantation
Sophie Perie et al.
NEUROMUSCULAR DISORDERS (2006)
Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino
Shantanu Karkare et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2006)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: Indication for steric hindrance of SR protein binding sites
A Aartsma-Rus et al.
OLIGONUCLEOTIDES (2005)
Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse
EW Yeung et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
The dystrophin glycoprotein complex - Signaling strength and integrity for the sarcolemma
KA Lapidos et al.
CIRCULATION RESEARCH (2004)
Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy
P Dowling et al.
BIOCHEMICAL JOURNAL (2004)
Regenerative potential of human skeletal muscle during aging
V Renault et al.
AGING CELL (2002)
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
A Aartsma-Rus et al.
NEUROMUSCULAR DISORDERS (2002)
Historical claims and current interpretations of replicative aging
WE Wright et al.
NATURE BIOTECHNOLOGY (2002)
分享论文
